AOSL on Nasdaq
Alpha & Omega Semiconductor
Semiconductor company in the United States.1
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with CHIPMOS TECHNOLOGIES INC, DAQO or Kulicke & Soffa Industries, or pick any stock.
- TickerAOSL on Nasdaq1
- IndustrySemiconductors & Related Devices1
- HeadquartersSunnyvale1
- Websiteaosmd.com
- Business address475 Oakmead Parkway, Sunnyvale, Ca 940854
- Filer categoryAccelerated filer4
See how the biggest companies compare on our leaderboards

Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Power Discrete brought in 64% of the revenue Alpha & Omega Semiconductor broke down this way in fiscal 2026.
Products and services by year
| Products and services | 2024 | 2025 | 2026 |
|---|---|---|---|
| Power Discrete | $426.1M | $449.5M | $437.8M |
| Power Ic | $205.8M | $229.9M | $233.9M |
| Packaging and testing services | $4.1M | $2.9M | $7.3M |
Regions
Hong Kong brought in 96% of the revenue Alpha & Omega Semiconductor broke down this way in fiscal 2026.
Regions by year
| Regions | 2024 | 2025 | 2026 |
|---|---|---|---|
| Hong Kong | $524.8M | $617.6M | $649.3M |
| China | $95.4M | $58.5M | $16.4M |
| United States | $4.9M | $4.1M | $7.3M |
| Other Countries | $22.2M | $14.3M | $4.1M |
| South Korea | $10.0M | $1.7M | $1.9M |
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue72¢$527.4M
- Research and development14¢$103.9M
- Selling, general and admin12¢$90.9M
- Income tax1¢$7.5M
Out of $678.9M in revenue.3 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Revenue | $678.9M | $696.2M | $657.3M |
| Cost of goods sold | $527.4M | $535.2M | $485.4M |
| Gross profit | $151.5M | $161.0M | $171.9M |
| Research and development | $103.9M | $94.3M | $89.9M |
| Selling, general and administrative | $90.9M | $95.2M | $85.7M |
| Total operating expenses | $194.7M | $189.4M | $175.7M |
| Operating loss | -$43.2M | -$28.4M | -$3.8M |
| Other income (loss), net | $4.4M | -$1.0M | -$73.0K |
| Interest income | $4.0M | $4.3M | $5.2M |
| Interest expenses | -$775.0K | -$2.6M | -$4.0M |
| Net loss before income taxes and equity method investment income (loss) | -$35.6M | -$27.8M | -$2.6M |
| Income tax expense (benefit) | $7.5M | -$8.6M | $3.6M |
| Net loss before equity method investment income (loss) | -$43.1M | -$19.2M | -$6.3M |
| Equity method investment income (loss) | $834.0K | -$77.8M | -$4.8M |
| Net loss | -$42.3M | -$97.0M | -$11.1M |
| Net loss | -$42.3M | -$97.0M | -$11.1M |
| Basic (in dollars per share) | -$1.41 | -$3.30 | -$0.39 |
| Diluted (in dollars per share) | -$1.41 | -$3.30 | -$0.39 |
| Basic (in shares) | 30.0M shares | 29.4M shares | 28.2M shares |
| Diluted (in shares) | 30.0M shares | 29.4M shares | 28.2M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Cash and cash equivalents | $180.8M | $153.1M | $175.1M |
| Restricted cash | $654.0K | $419.0K | $413.0K |
| Accounts receivable, net | $42.8M | $34.8M | |
| Inventories | $201.4M | $189.7M | |
| Other current assets | $12.3M | $18.2M | |
| Total current assets | $437.9M | $396.2M | |
| Property, plant and equipment, net | $314.7M | $314.1M | |
| Operating lease right-of-use assets, net | $22.3M | $21.3M | |
| Intangible assets, net | $1.3M | $269.0K | |
| Equity method investment | $142.7M | $279.1M | |
| Deferred income tax assets | $8.6M | $599.0K | |
| Other long-term assets | $36.1M | $22.8M | |
| Total assets | $963.6M | $1.0B | |
| Accrued liabilities | $57.7M | $59.0M | |
| Income taxes payable | $2.8M | $1.8M | |
| Short-term debt | $3.1M | $11.9M | |
| Deferred revenue | $726.0K | $0 | |
| Finance lease liabilities | $1.1M | $1.0M | |
| Operating lease liabilities | $6.3M | $5.0M | |
| Total current liabilities | $127.4M | $154.5M | |
| Long-term debt | $537.0K | $14.9M | |
| Income taxes payable - long-term | $4.8M | $4.2M | |
| Deferred income tax liabilities | $11.9M | $13.2M | |
| Finance lease liabilities - long-term | $189.0K | $1.3M | |
| Operating lease liabilities - long-term | $16.8M | $16.9M | |
| Other long-term liabilities | $4.1M | $7.0M | |
| Total liabilities | $165.7M | $212.0M | |
| Authorized: 10,000 shares; issued and outstanding: none at June 30, 2026 and 2025 | $0 | $0 | |
| Authorized: 100,000 shares; issued and outstanding: 38,294 shares and 30,253 shares, respectively at June 30, 2026 and 37,127 shares and 30,009 shares, respectively at June 30, 2025 | $77.0K | $74.0K | |
| Treasury shares at cost; 8,041 shares at June 30, 2026 and 7,118 shares at June 30, 2025 | -$97.1M | -$79.1M | |
| Additional paid-in capital | $406.9M | $379.8M | |
| Accumulated other comprehensive loss | -$3.5M | -$12.4M | |
| Retained earnings | $491.5M | $533.9M | |
| Total shareholders' equity | $797.9M | $822.3M | |
| Total liabilities and shareholders' equity | $963.6M | $1.0B | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | |
| Preferred stock, shares issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, shares outstanding (in shares) | 0 shares | 0 shares | |
| Common shares, par value (in dollars per share) | $0.00 | $0.00 | |
| Common shares, authorized (in shares) | 100.0M shares | 100.0M shares | |
| Common stock, shares issued (in shares) | 38.3M shares | 37.1M shares | |
| Common stock, shares outstanding (in shares) | 30.3M shares | 30.0M shares | |
| Treasury shares (in shares) | 8.0M shares | 7.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2026-06-30 | 2025-06-30 | 2024-06-30 |
|---|---|---|---|
| Net loss before equity method investment income (loss) | -$42.3M | -$97.0M | -$11.1M |
| Depreciation and amortization | $57.3M | $62.4M | $53.8M |
| Equity method investment income (loss) | -$834.0K | $77.8M | $4.8M |
| Gain on recovery of privately-held investment | -$290.0K | $0 | $0 |
| Share-based compensation expense | $26.7M | $29.6M | $21.6M |
| Deferred income taxes, net | -$9.3M | -$13.3M | -$880.0K |
| Loss on disposal of property and equipment | $54.0K | $80.0K | $78.0K |
| Impairment of property and equipment | $334.0K | $1.0M | $0 |
| Impairment of privately-held investment | $0 | $100.0K | $0 |
| Accounts receivable | -$8.0M | -$22.2M | $9.9M |
| Inventories | -$11.7M | $6.1M | -$12.5M |
| Other current and long-term assets | $1.4M | -$465.0K | $1.9M |
| Payable related to equity investee, net | -$7.1M | $2.1M | $1.7M |
| Accounts payable | -$12.1M | $13.3M | -$2.4M |
| Income taxes payable | $1.6M | -$399.0K | -$2.0M |
| Deferred revenue | $726.0K | -$2.6M | -$5.5M |
| Accrued and other liabilities | -$12.8M | -$26.9M | -$33.8M |
| Net cash (used in) provided by operating activities | -$16.3M | $29.7M | $25.7M |
| Proceeds from sale of equity interest in the JV Company | $147.7M | $0 | $0 |
| Purchases of property and equipment | -$51.8M | -$37.2M | -$37.1M |
| Purchases of intangible assets | -$569.0K | $0 | $0 |
| Proceeds from sale of property and equipment | $11.0K | $61.0K | $383.0K |
| Proceeds from sale of privately-held investment | $290.0K | $0 | $0 |
| Government grants related to equipment | $145.0K | $678.0K | $961.0K |
| Loan receivable from suppliers | -$9.7M | $0 | $0 |
| Net cash provided by (used in) investing activities | $86.1M | -$36.4M | -$35.7M |
| Withholding tax on restricted stock units | -$7.5M | -$10.7M | -$7.7M |
| Proceeds from exercise of stock options and ESPP | $8.0M | $7.8M | $10.1M |
| Payments for repurchase of common shares | -$18.2M | $0 | $0 |
| Repayments of borrowings | -$23.1M | -$11.7M | -$11.5M |
| Principal payments on finance leases | -$1.0M | -$935.0K | -$867.0K |
| Net cash used in financing activities | -$41.8M | -$15.5M | -$9.9M |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -$48.0K | $227.0K | -$126.0K |
| Net increase (decrease) in cash, cash equivalents and restricted cash | $27.9M | -$22.0M | -$20.1M |
| Cash paid for interest | $1.1M | $2.9M | $2.6M |
| Cash paid for income taxes | $17.5M | $4.6M | $5.8M |
| Property and equipment purchased but not yet paid | $10.8M | $10.6M | $7.4M |
| Reissuance of treasury stock | $148.0K | $155.0K | $152.0K |
| Foreign currency translation adjustment, tax | $1.9M | -$43.0K | $876.0K |
Timeline
- 2000Founded Founded1
Recent filings
- Sep 30, 2026DEF 14A
- Sep 30, 2026DEFA14A DEFA14A FY2026
- Sep 30, 2026ARS
- Sep 11, 20264
- Sep 11, 20264
- Aug 27, 202610-K
- Aug 27, 2026S-8
- Aug 14, 20264
- Aug 12, 20268-K
- Aug 10, 2026SCHEDULE 13G/A
- Aug 7, 2026SCHEDULE 13G
- Jul 21, 20264
- Jul 17, 20263
- Jul 17, 20264
- Jul 16, 2026144
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websiteaosmd.com1
- WikidataQ30273331
- SEC EDGARCIK 1387467
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5Company websiteAlpha & Omega Semiconductor photo
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14